Neoadjuvant therapy helps partial nephrectomy for kidney cancer
Neoadjuvant therapy is treatment that is given before surgery to help [...]
Stereotactic ablative radiotherapy (SABR) for advanced kidney cancer
Stereotactic ablative body radiotherapy (SABR) uses an intense beam of radiation focused [...]
Minimally invasive, maximally effective: The rise of Interventional Oncology
Interventional oncology is a type of interventional radiology. It is [...]
Metastasis-Directed Radiotherapy Shows Improved Kidney Cancer Outcomes
A recent phase 2 clinical trial presented at the 2025 [...]
ASTRO 2024: SABR for primary kidney cancer – Is it ready for ‘primetime’?
In this presentation at the 2024 American Society for Radiation [...]
Clinical impact of the CARMENA trial on cytoreductive nephrectomy in the USA
A recent study looked at whether the use of cytoreductive [...]
Biopsy of small renal masses leads to fewer radical nephrectomies
This study looks at how how the biopsy of small [...]
Factors affecting outcomes after nephrectomy for metastatic kidney cancer
Nephrectomy is surgery to remove all or part of a [...]
Kidney function 5 years after SABR for primary kidney cancer
Stereotactic ablative body radiotherapy (SABR) uses high doses of radiation [...]
SABR for older patients with inoperable kidney cancer
The incidence of renal cell carcinoma (RCC) has increased worldwide [...]
